Skip to main content
. 2019 Sep 15;2019:9074908. doi: 10.1155/2019/9074908

Table 1.

Association between AURKA gene polymorphisms and Wilms tumor susceptibility.

Genotype Cases (N = 143) Controls (N = 531) P a Crude OR (95% CI) P Adjusted OR (95% CI)b P b
rs1047972 C>T (HWE = 0.598)
 CC 110 (76.92) 412 (77.59) 1.00 1.00
 CT 30 (20.98) 110 (20.72) 0.89 (0.57–1.39) 0.613 0.89 (0.57–1.39) 0.622
 TT 3 (2.10) 9 (1.69) 1.09 (0.29–4.08) 0.898 1.10 (0.29–4.10) 0.891
 Additive 0.945 1.05 (0.71–1.55) 0.809 1.04 (0.71–1.54) 0.834
 Dominant 33 (23.08) 119 (22.41) 0.866 1.04 (0.67–1.61) 0.865 1.03 (0.66–1.60) 0.889
 Recessive 140 (97.90) 522 (98.31) 0.746 1.24 (0.33–4.65) 0.747 1.22 (0.33–4.59) 0.764

rs2273535 T>A (HWE = 0.701)
 TT 66 (46.15) 234 (44.07) 1.00 1.00
 TA 65 (45.45) 234 (44.07) 0.82 (0.57–1.16) 0.263 0.82 (0.57–1.17) 0.265
 AA 12 (8.39) 63 (11.86) 0.56 (0.29–1.08) 0.084 0.56 (0.29–1.08) 0.085
 Additive 0.502 0.88 (0.67–1.17) 0.377 0.88 (0.67–1.17) 0.374
 Dominant 77 (53.85) 297 (55.93) 0.656 0.92 (0.63–1.33) 0.656 0.92 (0.63–1.33) 0.659
 Recessive 131 (91.61) 468 (88.14) 0.241 0.68 (0.36–1.30) 0.244 0.68 (0.35–1.29) 0.237

rs8173 G>C (HWE = 0.272)
 GG 71 (49.65) 196 (36.91) 1.00 1.00
 GC 54 (37.76) 263 (49.53) 0.51 (0.35–0.73) 0.0003 0.50 (0.35–0.73) 0.0002
 CC 18 (12.59) 72 (13.56) 0.62 (0.35–1.08) 0.090 0.61 (0.35–1.08) 0.088
 Additive 0.018 0.74 (0.56–0.98) 0.033 0.75 (0.56–0.99) 0.040
 Dominant 72 (50.35) 335 (63.09) 0.006 0.59 (0.41–0.86) 0.006 0.60 (0.42–0.88) 0.008
 Recessive 125 (87.41) 459 (86.44) 0.762 0.92 (0.53–1.60) 0.762 0.92 (0.53–1.61) 0.781

OR, odds ratio; CI, confidence interval; HWE, Hardy–Weinberg equilibrium. aχ2 test for genotype distributions between Wilms tumor patients and controls; badjusted for age and gender.